Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review

Convalescent plasma therapy (CP) has long been used to prevent and treat various infectious diseases before COVID-19 such as SARS, MERS, and H1N1. Because the viral and clinical characteristics of COVID-19 share the similarities between SARS and MERS, CP treatment could be a promising treatment opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Munir, M.A., Tandiabang, P.A., Setyawati, T., Basry, A., Cyio, A.D., Rahman, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028602/
https://www.ncbi.nlm.nih.gov/pubmed/33839300
http://dx.doi.org/10.1016/j.tracli.2021.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028602/
https://www.ncbi.nlm.nih.gov/pubmed/33839300
http://dx.doi.org/10.1016/j.tracli.2021.03.005

Ejemplares similares